We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+12.41%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$2.41B
AUM Growth
+$457M
(+23%)
Cap. Flow
+$309M
Cap. Flow
% of AUM
12.8%
Top 10 Holdings %
Top 10 Hldgs %
6.55%
Holding
3,413
New
1,082
Increased
689
Reduced
503
Closed
1,137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$16.5M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$16.2M |
| 3 |
NVIDIA
NVDA
|
+$15.8M |
| 4 |
Philip Morris
PM
|
+$15.3M |
| 5 |
Microsoft
MSFT
|
+$14.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$13.3M |
| 2 |
CRH
CRH
|
+$11.8M |
| 3 |
GE Aerospace
GE
|
+$11.8M |
| 4 |
Johnson & Johnson
JNJ
|
+$11M |
| 5 |
Vertiv
VRT
|
+$10.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.02% |
| 2 | Technology | 16.8% |
| 3 | Industrials | 12.48% |
| 4 | Consumer Discretionary | 11.54% |
| 5 | Healthcare | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
MIRA Pharmaceuticals
MIRA
$35.3M
| $26.5K | ﹤0.01% |
+21,873
| New | +$25.3K |
|
|
IMMP
2127
Immutep
IMMP
$57M
| $26.1K | ﹤0.01% |
15,927
+4,856
| +44% | +$8.46K |
|
2128
SeaStar Medical
ICU
$13.7M
| $26K | ﹤0.01% |
6,098
+4,867
| +395% | +$56.1K |
|
2129
Ovid Therapeutics
OVID
$440M
| $25.9K | ﹤0.01% |
78,420
-14,734
| -16% | -$4.44K |
|
2130
Bridger Aerospace
BAER
$112M
| $25.6K | ﹤0.01% |
+13,256
| New | +$20.4K |
|
|
OKUR
2131
OnKure Therapeutics
OKUR
$160M
| $25.4K | ﹤0.01% |
+10,643
| New | +$27.9K |
|
|
AMOD
2132
Alpha Modus Holdings
AMOD
$17.7M
| $25.3K | ﹤0.01% |
+555
| New | +$27.7K |
|
|
CNTN
2133
Canton Strategic Holdings
CNTN
$157M
| $25.2K | ﹤0.01% |
+12,911
| New | +$18.1K |
|
|
YQ
2134
17 Education & Technology Group
YQ
$19.6M
| $25.1K | ﹤0.01% |
+11,460
| New | +$22.2K |
|
2135
Broadwind
BWEN
$92.9M
| $24.8K | ﹤0.01% |
+13,702
| New | +$23.1K |
|
2136
Vince Holding Corp
VNCE
$77.6M
| $24.4K | ﹤0.01% |
+16,973
| New | +$27.2K |
|
2137
Passage Bio
PASG
$14.7M
| $24.4K | ﹤0.01% |
3,044
+774
| +34% | +$5.66K |
|
2138
Televisa
TV
$1.47B
| $24.4K | ﹤0.01% |
11,125
-32,603
| -75% | -$63.9K |
|
2139
OLB
OLB
$4.55M
| $24.2K | ﹤0.01% |
+12,967
| New | +$20.1K |
|
2140
Xilio Therapeutics
XLO
$60.2M
| $23.6K | ﹤0.01% |
+2,480
| New | +$26.2K |
|
2141
Imunon
IMNN
$6.43M
| $23.5K | ﹤0.01% |
2,255
+593
| +36% | +$8.1K |
|
|
ZSTK
2142
ZeroStack Corp
ZSTK
$3.28M
| $23.4K | ﹤0.01% |
1,033
+430
| +71% | +$10.4K |
|
2143
Tenon Medical
TNON
$3.3M
| $23.1K | ﹤0.01% |
+23,622
| New | +$25.9K |
|
|
OPI
2144
DELISTED
Office Properties Income Trust
OPI
| $22.9K | ﹤0.01% |
92,642
+49,879
| +117% | +$14K |
|
|
IMA
2145
ImageneBio Inc
IMA
$65.5M
| $22.8K | ﹤0.01% |
1,417
-3,287
| -70% | -$48.3K |
|
2146
Nexalin Technology
NXL
$7.37M
| $22.6K | ﹤0.01% |
+22,144
| New | +$31.1K |
|
2147
Moleculin Biotech
MBRX
$15.5M
| $22.4K | ﹤0.01% |
2,969
+2,506
| +541% | +$51.4K |
|
2148
Iveda Solutions
IVDA
$2.6M
| $22.3K | ﹤0.01% |
+10,984
| New | +$24.6K |
|
2149
IRIDEX
IRIX
$15.3M
| $22.3K | ﹤0.01% |
25,211
+14,900
| +145% | +$15.2K |
|
2150
Flux Power
FLUX
$12.1M
| $21.9K | ﹤0.01% |
14,526
-2,403
| -14% | -$3.9K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q2 2025 Portfolio in Review
As of Q2 2025, XTX Topco held 3,413 positions worth $2.41B, up 23% from $1.95B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.
XTX Topco deployed $309M of net new capital in Q2 2025, opening 1,082 new positions and adding to 689 existing holdings. Its largest new stake was Amazon: 83,425 shares worth $18.3M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Netflix, an estimated $13.3M trimmed.
- XTX Topco's largest Q2 2025 buy was Amazon: 83,425 shares worth $18.3M.
- XTX Topco added most to NVIDIA in Q2 2025, an estimated $15.8M increase.
- XTX Topco's biggest Q2 2025 reduction was Netflix, cutting an estimated $13.3M.
- XTX Topco fully exited CRH in Q2 2025, selling an estimated $11.8M.
- XTX Topco's ten largest holdings make up 6.5% of its $2.41B portfolio in Q2 2025.
- XTX Topco opened 1,082 new positions and closed 1,137 in Q2 2025.
- XTX Topco's portfolio value rose 23% quarter-over-quarter to $2.41B.
Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.